Two Houston entrepreneurs — Molly Voorhees (left) and Christina Milligan — have launched a new line of sanitizing products. Photo via instagram.com/cobaltclean

Houstonians Molly Voorhees and Christina Milligan have officially launched a line of hand sanitizing and surface cleaning products that blend the importance of cleanliness and safety with the added value of accessibility and a refined appearance.

The products make up the entrepreneurs' new brand, Cobalt, that Voorhees, president of Beck's Prime, and Milligan, an organizing and style expert, first conceptualized in March. As working parents of young children, the two women wanted to create a line of sanitizing products that boosted their confidence in the safety of their environments amid a pandemic and that they'd be proud to pull out of their purse on short notice.

"Cleaning products are in your bathroom or are in an ugly looking bottle or the back of our restaurant in massive chemical containers. There is really nothing for the on-the-go market," Voorhees says.

Too, the women didn't want to stop at hand sanitizer. Instead, they sought to encourage and educate clientele on the importance of cleaning high-touch surfaces, like phones, steering wheels, sunglasses, and the likes.

"It really resonated with us that your hands are only as clean as the surfaces that you touch," Milligan says. "We wanted it to be very approachable and easy to understand and also discrete. We didn't want anyone to feel ashamed if they pulled out a bottle of Lysol on a table."

The result was six FDA-approved sanitizers, sprays, keychains, and to-go kits that eliminate 99.9 percent of bacteria and viruses in easy to access, personal-sized, contemporary bottles, ranging from $14 to $30. The products are designed to be free of harsh, alcoholic odors and come in scents like peppermint and bubble gum.


The duo business women wanted to avoid harsh alcoholic smells and opted for calming and fun scents. Photo courtesy of Cobalt

Each item in the line boasts sleek, trendy designs in a cool blue hue. And while they look quite polished today, bringing the line to launch started off as a somewhat messy process.

"We kinda thought it would be easy. We would just put cleaner in a 4-ounce bottle and that would be fine," Milligan says.

But due to the high demand for chemical products in the pandemic and the way that industrial filling lines are set up, producing cleaning products in personal-sized bottles proved difficult. The women, who became known as the "the girls who want to put cleaner in their purse," were initially met with a resounding "no" from large chemical corporations.

However, by the summer the duo was able to make more headway. They were nearing production with a chemical partner when they learned of a local business who could produce their product by hand all within the Bayou City.

"It turned out through a connection we were making with labels that we discovered [William Price Distilling Company] that was right in our backyard in Houston that was newly filling bottles," Milligan says. "They were employing out of work restaurant staff. Molly and I both felt really strongly about that."

Voorhees and Milligan quickly partnered up with the Garden Oaks-Oak Forest distillery and have since produced roughly 2,500 units of their various products.

In fact, the line is decidedly Houston-based. In addition to William Price, Cobalt was also created with the help of Houston Labels for design. Deutser helped the team from a business management perspective. And the custom scents were developed by Clarity Fragrance near Memorial City.

As of press time, the products are available for purchase online and in area boutiques, including Emerson Sloan, Lexington Boutique, Zadok Jewelers, Therapy Hair Studio, and The Chocolate Bar. They aim to expand to more stores and markets and adapt the line based on demand.

"We feel so fortunate that we have a variety of products," Voorhees says. "It's always my belief that the consumer will tell you what they want and you go in that direction."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.

Pioneering Houston biotech startup expands to Brazil for next phase

On the Move

Houston biotech company Cemvita has expanded into Brazil. The company officially established a new subsidiary in the country under the same name.

According to an announcement made earlier this month, the expansion aims to capitalize on Brazil’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, which was enacted in 2024. The company said the expansion also aims to coincide with the 2025 COP30, the UN’s climate change conference, which will be hosted in Brazil in November.

Cemvita utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals.

“For decades Brazil has pioneered the bioeconomy, and now the time has come to create the future of the circular bioeconomy,” Moji Karimi, CEO of Cemvita, said in a news release. “Our vision is to combine the innovation Cemvita is known for with Brazil’s expertise and resources to create an ecosystem where waste becomes opportunity and sustainability drives growth. By joining forces with Brazilian partners, Cemvita aims to build on Brazil’s storied history in the bioeconomy while laying the groundwork for a circular and sustainable future.”

The Fuel of the Future Law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

Cemvita agreed to a 20-year contract that specified it would supply up to 50 million gallons of SAF annually to United Airlines in 2023.

"This is all made possible by our innovative technology, which transforms carbon waste into value,” Marcio Da Silva, VP of Innovation, said in a news release. “Unlike traditional methods, it requires neither a large land footprint nor clean freshwater, ensuring minimal environmental impact. At the same time, it produces high-value green chemicals—such as sustainable oils and biofuels—without competing with the critical resources needed for food production."

In 2024, Cemvita became capable of generating 500 barrels per day of sustainable oil from carbon waste at its first commercial plant. As a result, Cemvita quadrupled output at its Houston plant. The company had originally planned to reach this milestone in 2029.

---

This story originally appeared on our sister site, EnergyCapitalHTX.